Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4–5 Years After a Primary 3-Dose Schedule
Conclusions:
Antidengue NAb levels can be boosted to levels at least as high as, or higher than those observed after completion of the primary 3-dose series, with an additional dose of CYD-TDV 4–5 years after the standard 3-dose vaccination schedule.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
More News: Brazil Health | Colombia Health | Dengue Fever | Endemics | Eyes | Honduras Health | Infectious Diseases | Mexico Health | Pediatrics | Study | Vaccines